The con here is the opposite of what takes place at other companies that you like to talk about. Other companies work to inflate and exaggerate their products and capabilities to inflate their stockprice. Sintx has continually downplayed its tech and i'd say worked to keep its stock undervalued; with the exception of the coordinated pump in 2020 on COVID news so it could raise funds to start the armor business/eventually acquire TA&T. Once those assets were acquired, the same shenanigans immediately resumed and we saw two RS larger than ever before. Those excessively large RS created huge cost basis for those that hold preferred and warrants, that if im not mistaken, represents very large tax shelters. Im watching a scheme similar to this transpire at another stock im watching. So far its going exactly as i predicted based partly on this. However that company, unlike Sintx, has no real potential. It needs hype and continual misleading information released by mgmt so funds can convert their notes into shares. Mgmt issued themselves preferred that pays interest and rounds up to the nearest whole share so mgmt has every incentive to see more RS occur to harvest that cost basis.
What did they accomplish by hiding their more valuable patent behind a less valuable patent? Well, they reduced potential excitement and possible increase in stock price allowing them to sell an offering to pre-IPO investors, as well as a few others, at potentially cheaper prices than what might have occurred had they properly released a PR about the more important patent. Or even had they done a 1-2 punch with PR's announcing both patents the way they did in September & December announcing allowances. Its also interesting that the stockprice did not move mcuh in comparison to September announcement, when they announced patent allowance in December given that patent is far more important than the one that they announced in September which did move the stockprice so they could raise funds.
It also allowed Anson and its family of funds to short the stock post offering and do their customary 50% haircut before management began to purchase shares providing support. Oddly there has not been a pump in price post offering which usually happens.
Then again what occured could have happened anyways because the stock here is controlled and heavily manipulated. The core concept seems to be to not attract attention...at least not yet. That could be changing now that Pre-IPO investors have returned like MedTech and management has begun to buy shares. Even additional Anson family of funds has acquired a nice chunk of shares from market instead of usually getting them from offerings. Management takes care of certain shareholders for sure.
AI
